NATH BIO-GENES (INNATH BIO-GENES (INNATH BIO-GENES (IN

NATH BIO-GENES (IN

No trades
See on Supercharts
Market capitalization
‪3.57 B‬INR
‪350.11 M‬INR
‪2.34 B‬INR
‪7.29 M‬
Beta (1Y)
0.67

About NATH BIO-GENES (IN

CEO
Satish Laxminarayan Kagliwal
Headquarters
Mumbai
Employees (FY)
433
Founded
1993
ISIN
INE448G01010
FIGI
BBG005XNKKG7
Nath Bio-Genes (India) Ltd. engages in the production and marketing of seeds. The firm offers categories of seeds including cereals, fiber and oil seeds, nutritional supplements, and vegetables. It operates through the Agriculture Activities and Trading Activities segments. The company was founded on July 14, 1993 and is headquartered in Aurangabad, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of NATHBIOGEN is 191.25 INR — it has increased by 0.63% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange NATH BIO-GENES (IN stocks are traded under the ticker NATHBIOGEN.
NATH BIO-GENES (IN is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
NATHBIOGEN stock is 4.77% volatile and has beta coefficient of 0.67. Check out the list of the most volatile stocks — is NATH BIO-GENES (IN there?
NATHBIOGEN earnings for the last quarter are 2.05 INR per share, whereas the estimation was 2.13 INR resulting in a −3.76% surprise. The estimated earnings for the next quarter are 4.37 INR per share. See more details about NATH BIO-GENES (IN earnings.
NATH BIO-GENES (IN revenue for the last quarter amounts to ‪330.58 M‬ INR despite the estimated figure of ‪293.69 M‬ INR. In the next quarter revenue is expected to reach ‪595.04 M‬ INR.
Yes, you can track NATH BIO-GENES (IN financials in yearly and quarterly reports right on TradingView.
NATHBIOGEN stock has fallen by 1.16% compared to the previous week, the month change is a 5.84% rise, over the last year NATH BIO-GENES (IN has showed a 15.91% increase.
NATHBIOGEN net income for the last quarter is ‪13.20 M‬ INR, while the quarter before that showed ‪20.34 M‬ INR of net income which accounts for −35.11% change. Track more NATH BIO-GENES (IN financial stats to get the full picture.
Today NATH BIO-GENES (IN has the market capitalization of ‪3.61 B‬, it has increased by 2.30% over the last week.
Yes, NATHBIOGEN dividends are paid annually. The last dividend per share was 2.00 INR. As of today, Dividend Yield (TTM)% is 1.05%. Tracking NATH BIO-GENES (IN dividends might help you take more informed decisions.
Like other stocks, NATHBIOGEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NATH BIO-GENES (IN stock right from TradingView charts — choose your broker and connect to your account.
NATHBIOGEN reached its all-time high on May 10, 2018 with the price of 585.00 INR, and its all-time low was 20.00 INR and was reached on Jan 28, 2014.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 433.00 employees. See our rating of the largest employees — is NATH BIO-GENES (IN on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NATH BIO-GENES (IN technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NATH BIO-GENES (IN stock shows the sell signal. See more of NATH BIO-GENES (IN technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NATH BIO-GENES (IN EBITDA is ‪519.02 M‬ INR, and current EBITDA margin is 21.25%. See more stats in NATH BIO-GENES (IN financial statements.